Flow Medical รีทวีตแล้ว

We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the United States in Europe, this landmark trial compares EKOS (Ultrasound Assisted Thrombolysis) with Anticoagulation vs Anticoagulation Alone in the treatment of intermediate-high risk PE patients. The study was a collaboration between The PERT Consortium, University Medical Center Mainz, and Boston Scientific. We extend our congratulations to all investigators and enrollment sites involved in this one-of-a-kind trial that will inform strategies for PE treatment around the world.#pe #pulmonaryembolism #hipeitho @bostonsci @bsc_pi
Learn more about HI-PEITHO: t.co/u5SkH7GUiS

English





























